Drug recall · January 22, 2020
Dutasteride Capsules recall
Why: Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.
- Lots / codes
Lots: 25246, Exp. 02/2021; 24532, Exp. 10/2020; 23647, Exp. 06/2020
- Quantity
- 3,989 cartons
- Company
- AVKARE Inc., Pulaski, TN
- Distribution
- Nationwide in the USA.
- Initiated
- January 7, 2020 · Voluntary: Firm initiated
- Classified
- January 13, 2020
- Reported
- January 22, 2020
- Ended
- July 14, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Dutasteride
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.